MedTrace Logo

Adverse Outcomes Following Female Genital Fistula Repair

NCT05437939 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 802

Last updated 2025-05-07

No results posted yet for this study

Summary

Following genital fistula repair, fistula repair breakdown and recurrence, persistent and incidence incontinence are major adverse outcomes, limiting women's health and wellbeing. Using a prospective design, the investigators seek to identify modifiable risk factors to establish key targets for intervention, followed by qualitative work to refine the feasibility and acceptability of potential intervention strategies.

Conditions

  • Female Genital Fistula
  • Incontinence

Sponsors & Collaborators

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • Infectious Diseases Research Collaboration, Uganda

    collaborator OTHER

  • Makerere University

    collaborator OTHER

  • University of California, San Francisco

    lead OTHER

Principal Investigators

  • Alison El Ayadi, ScD · University of California, San Francisco

Eligibility

Min Age
15 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-05-20
Primary Completion
2026-03-31
Completion
2026-07-31

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05437939 on ClinicalTrials.gov